Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Accured ExpensesChange in TaxesGains from Equity InvestmentsNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Gains from Sales and Divestitures (2016 - 2023)

Historic Gains from Sales and Divestitures for Zepp Health (ZEPP) over the last 8 years, with Q4 2023 value amounting to $224537.0.

  • Zepp Health's Gains from Sales and Divestitures rose 2590.15% to $224537.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $224537.0, marking a year-over-year increase of 2590.15%. This contributed to the annual value of $224537.0 for FY2023, which is 1885.69% up from last year.
  • According to the latest figures from Q4 2023, Zepp Health's Gains from Sales and Divestitures is $224537.0, which was up 2590.15% from $178343.4 recorded in Q4 2022.
  • In the past 5 years, Zepp Health's Gains from Sales and Divestitures registered a high of $1.6 million during Q4 2019, and its lowest value of $80968.1 during Q4 2021.
  • Its 5-year average for Gains from Sales and Divestitures is $449810.1, with a median of $178343.4 in 2022.
  • Per our database at Business Quant, Zepp Health's Gains from Sales and Divestitures surged by 87115.72% in 2019 and then plummeted by 9078.59% in 2020.
  • Over the past 5 years, Zepp Health's Gains from Sales and Divestitures (Quarter) stood at $1.6 million in 2019, then tumbled by 90.79% to $148926.0 in 2020, then tumbled by 45.63% to $80968.1 in 2021, then skyrocketed by 120.26% to $178343.4 in 2022, then grew by 25.9% to $224537.0 in 2023.
  • Its Gains from Sales and Divestitures was $224537.0 in Q4 2023, compared to $178343.4 in Q4 2022 and $80968.1 in Q4 2021.